Stellon A J, Davies A, Compston J, Williams R
Q J Med. 1985 Nov;57(223):783-90.
Assessment for both trabecular and cortical osteoporosis was carried out in 36 unselected patients with chronic cholestatic liver disease of whom a number had received corticosteroids during the course of their illness. Symptoms suggestive of osteoporosis were present in 42 per cent of patients of whom 11 per cent had evidence of one or more wedged or collapsed vertebrae. There was a highly significant decrease in the cortical area (total area ratio of the second metacarpal (p = 0.05), bone mineral content at the metaphyseal site of the radius (p = 0.01) and the total trabecular bone volume of the iliac crest biopsies (p = 0.005) in the 31 female patients when compared with age and sex-matched healthy controls). There was a nonsignificant decrease in total trabecular bone volume of the iliac crest and bone mineral content of the radial metaphysis in the males compared with age and sex-matched controls but the cortical plate thickness of the iliac crest (p = 0.005) and bone mineral content of the radial diaphysis (p = 0.02) were significantly higher. In total, 42 per cent of patients had evidence of either excessive cortical (28 per cent) and/or trabecular (36 per cent) bone loss as judged by radiological and histological criteria. Only the total trabecular bone volume of the iliac crest, of all the parameters measured was significantly (p = 0.02) lower in patients with backache compared with those without back pain. Significantly greater bone loss was demonstrated at all sites measured in those patients that were receiving or had received corticosteroids in the past.
对36例未经挑选的慢性胆汁淤积性肝病患者进行了小梁骨和皮质骨骨质疏松症评估,其中一些患者在病程中接受过皮质类固醇治疗。42%的患者有提示骨质疏松症的症状,其中11%有一个或多个楔形或压缩性椎体的证据。与年龄和性别匹配的健康对照组相比,31例女性患者的皮质面积(第二掌骨总面积比,p = 0.05)、桡骨干骺端骨矿物质含量(p = 0.01)和髂嵴活检的小梁骨总体积(p = 0.005)均有极显著下降。与年龄和性别匹配的对照组相比,男性髂嵴小梁骨总体积和桡骨干骺端骨矿物质含量有非显著下降,但髂嵴皮质板厚度(p = 0.005)和桡骨干骨矿物质含量(p = 0.02)显著更高。总体而言,根据放射学和组织学标准判断,42%的患者有皮质骨(28%)和/或小梁骨(36%)过度丢失的证据。在所有测量参数中,只有背痛患者的髂嵴小梁骨总体积显著低于(p = 0.02)无背痛患者。在过去接受或正在接受皮质类固醇治疗的患者中,所有测量部位的骨丢失都显著更大。